IMR Press / EJGO / Volume 31 / Issue 4 / pii/1630985259313-1389214586

European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Original Research
p16INK4a and low-grade cervical intraepithelial neoplasia. Diagnostic and therapeutic implications
Show Less
1 Department of Surgical Sciences, University of L’Aquila
2 Department of Pathology, San Salvatore Hospital, L’Aquila (Italy)
Eur. J. Gynaecol. Oncol. 2010, 31(4), 411–414;
Published: 10 August 2010
Abstract

The objectives of this study were to evaluate the evolution of a LSIL associated with p16INK4a overexpression and on the basis of this association, identify patients who would benefit from immediate treatment rather than a later follow-up. Two hundred and fortyfive cervical biopsies were studied: 199 (81.2%) were classified CIN 1, 18 (7.4%) CIN 2/3 while 28 (11.4%) were not pathological. Immunohistochemistry revealed that 22 of the 217 CIN samples (11%) were positive for the p16INK4a antigen. The results of the PCR-ELISA for the research and typing of the HPV in these 22 cases were: 14 (63.6%) HPV 16; three (13.6%) HPV 31; 2 (9%) HPV 33; one (4.6%) HPV 43; one (4.6%) HPV 45; one (4.6%) HPV 18. Colposcopic and histological tests performed at four- and eight-month follow-ups in these patients revealed worsening of the initial lesion. Hence, we conclude that immediate therapy would be of benefit in these patients.
Keywords
p16INK4a
HPV
LSIL
Share
Back to top